Systemic interleukin 10 administration inhibits brain tumor necrosis factor production in mice - PubMed (original) (raw)
Comparative Study
. 1997 Oct 8;336(2-3):197-202.
doi: 10.1016/s0014-2999(97)01225-9.
Affiliations
- PMID: 9384233
- DOI: 10.1016/s0014-2999(97)01225-9
Comparative Study
Systemic interleukin 10 administration inhibits brain tumor necrosis factor production in mice
E Di Santo et al. Eur J Pharmacol. 1997.
Abstract
Interleukin 10 is an antiinflammatory cytokine and inhibits the production of tumor necrosis factor. We have previously found that intracerebroventricular (i.c.v.) administration of recombinant human interleukin 10 inhibits brain tumor necrosis factor production induced by an i.c.v. injection of lipopolysaccharide in mice. In view of its possible pharmacological use, we have now studied whether interleukin 10 administered peripherally could inhibit brain tumor necrosis factor production. Mice were injected with recombinant human interleukin 10 (20 microg/mouse, i.v.) 10 min-24 h before lipopolysaccharide (2.5 microg, i.c.v.). Tumor necrosis factor was measured, using a bioassay, in brain homogenates 90 min after lipopolysaccharide. Recombinant human interleukin 10 administered i.v. between 10 min and 6 h before lipopolysaccharide markedly inhibited brain tumor necrosis factor production. We also measured the production of tumor necrosis factor by whole blood of these mice, and it was also markedly inhibited by recombinant human interleukin 10 treatment. In conclusion, systemic recombinant human interleukin 10 administration inhibits brain tumor necrosis factor production. suggesting its usefulness in tumor necrosis factor-mediated pathologies of the central nervous system.
Similar articles
- Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1 beta production in the brain without affecting the activation of the hypothalamus-pituitary-adrenal axis.
Di Santo E, Sironi M, Pozzi P, Gnocchi P, Isetta AM, Delvaux A, Goldman M, Marchant A, Ghezzi P. Di Santo E, et al. Neuroimmunomodulation. 1995 May-Jun;2(3):149-54. doi: 10.1159/000096885. Neuroimmunomodulation. 1995. PMID: 8646564 - Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.
Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gérard C, Delvaux A, De Groote D, Abramowicz D, Velu T, Goldman M. Marchant A, et al. Eur J Immunol. 1994 May;24(5):1167-71. doi: 10.1002/eji.1830240524. Eur J Immunol. 1994. PMID: 8181527 - Ciliary neurotrophic factor inhibits brain and peripheral tumor necrosis factor production and, when coadministered with its soluble receptor, protects mice from lipopolysaccharide toxicity.
Benigni F, Villa P, Demitri MT, Sacco S, Sipe JD, Lagunowich L, Panayotatos N, Ghezzi P. Benigni F, et al. Mol Med. 1995 Jul;1(5):568-75. Mol Med. 1995. PMID: 8529123 Free PMC article. - Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice.
Mengozzi M, Fantuzzi G, Faggioni R, Marchant A, Goldman M, Orencole S, Clark BD, Sironi M, Benigni F, Ghezzi P. Mengozzi M, et al. Immunology. 1994 Jun;82(2):207-10. Immunology. 1994. PMID: 7927490 Free PMC article.
Cited by
- Central Nervous System Parasitosis and Neuroinflammation Ameliorated by Systemic IL-10 Administration in Trypanosoma brucei-Infected Mice.
Rodgers J, Bradley B, Kennedy PG, Sternberg JM. Rodgers J, et al. PLoS Negl Trop Dis. 2015 Oct 27;9(10):e0004201. doi: 10.1371/journal.pntd.0004201. eCollection 2015. PLoS Negl Trop Dis. 2015. PMID: 26505761 Free PMC article. - The bacterial quorum-sensing signal molecule N-3-oxo-dodecanoyl-L-homoserine lactone reciprocally modulates pro- and anti-inflammatory cytokines in activated macrophages.
Glucksam-Galnoy Y, Sananes R, Silberstein N, Krief P, Kravchenko VV, Meijler MM, Zor T. Glucksam-Galnoy Y, et al. J Immunol. 2013 Jul 1;191(1):337-44. doi: 10.4049/jimmunol.1300368. Epub 2013 May 29. J Immunol. 2013. PMID: 23720811 Free PMC article. - Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity.
Bachis A, Colangelo AM, Vicini S, Doe PP, De Bernardi MA, Brooker G, Mocchetti I. Bachis A, et al. J Neurosci. 2001 May 1;21(9):3104-12. doi: 10.1523/JNEUROSCI.21-09-03104.2001. J Neurosci. 2001. PMID: 11312295 Free PMC article. - Peripheral anti-inflammatory cytokine Interleukin-10 treatment mitigates interleukin-1β - induced anxiety and sickness behaviors in adult male rats.
Munshi S, Parrilli V, Rosenkranz JA. Munshi S, et al. Behav Brain Res. 2019 Oct 17;372:112024. doi: 10.1016/j.bbr.2019.112024. Epub 2019 Jun 10. Behav Brain Res. 2019. PMID: 31195034 Free PMC article. - The p38alpha mitogen-activated protein kinase limits the CNS proinflammatory cytokine response to systemic lipopolysaccharide, potentially through an IL-10 dependent mechanism.
Bachstetter AD, Xing B, Van Eldik LJ. Bachstetter AD, et al. J Neuroinflammation. 2014 Oct 10;11:175. doi: 10.1186/s12974-014-0175-6. J Neuroinflammation. 2014. PMID: 25297465 Free PMC article.